- Coordinator
- GO Antimicrobial Technologies, Lda, Portugal
- Runs
- 1 August 2026 to 31 July 2028
- Status
- Running
- EU funding
- €500k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101308798
What the project is doing
In the project's own words, from its summary on CORDIS.
Catheter-related infections remain one of the most serious and costly complications in haemodialysis, affecting nearly 17.5% of catheterised patients each year and causing up to 15% mortality. Despite strict aseptic protocols and use of single-use catheter caps, infection rates continue to increase. Current approaches are inherently reactive, chemical- and antibiotic-dependent, fuelling antimicrobial resistance and generating significant medical waste.
The clinical and economic toll is severe, costing European healthcare systems over €1.7 billion every year. The GOcap®, developed by GOTECH Antimicrobial, introduces a paradigm shift in infection prevention. It is the first reusable, light-activated, graphene-based catheter cap that delivers continuous, antibiotic- and chemical-free antimicrobial action directly inside the catheter hub, the primary site of infection. Upon activation by near-infrared (NIR) light, graphene oxide (GO) generates a photothermal and photodynamic effect that destroys 99% of bacteria and fungi, including multidrug-resistant strains, without affecting patient tissues.
The device is self-contained, automated, and reusable for at least six months, reducing consumables, cost, and waste while improving patient safety and sustainability. SAFE-HD project will advance GOcap® from TRL4 to TRL6 through miniaturisation, design lock, and GLP-compliant validation, supported by ISO 13485-certified partners and clinical private and public dialysis collaborators (e.g. Diaverum, CHUSJ). Regulatory preparation (CE/FDA), quality management implementation, and market-readiness activities will ensure a clear and scalable pathway to market.
SAFE-HD will deliver a high-impact MedTech innovation: a new class of reusable, graphene-based antimicrobial devices that directly advance EU priorities on healthcare resilience and sustainability, driven by GOTECH’s multidisciplinary expertise in biomedical engineering, antimicrobial materials, and business.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| GO Antimicrobial Technologies, Lda | Porto | Portugal | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS